• Yi Zhang, Haifeng Zhang, Ya-Jun Lian, Yun-Qing Ma, Nan-Chang Xie, Xuan Cheng, and Lu Zhang.
• Department of Neurology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450000, China.
• Pain Res Manag. 2016 Jan 1; 2016: 8016065.

AbstractBackground. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) syndrome is an unusual cause of headache, mainly described in older adults, and is rare in children. Pain attacks may be severe, frequent, and prolonged. The therapeutic benefits of many drugs are disappointing. Patient and Methods. A 12-year-old boy suffered severe headache and toothache for 20 days. As treatment with nonsteroidal anti-inflammatory drugs, anticonvulsants, and steroids proved ineffective, he was treated with ipsilateral multisite subcutaneous injections of botulinum toxin A 70 U around the orbit, the temporal area, and the upper gum. Results. The pain had reduced in frequency and severity by the fourth day after treatment and had completely disappeared after 7 days. There were no side effects or recurrence during a subsequent 17-month follow-up period. Conclusion. Botulinum toxin A can be used to treat the first episode of SUNCT in children over the age of 12 years.

11 keywords...

hide…